Micardis (telmisartan)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Micardis (telmisartan), covering 2016-11-18 to 2016-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients [Phase 2]